Pharmaceutical Launch Planning & Commercial Excellence
Launching new products is how life sciences companies sustain revenue, replace products approaching loss of exclusivity, and compete in crowded therapeutic areas. Commercial leaders are navigating increasing complexity, from supply chain and manufacturing challenges to evolving market access dynamics and accelerated regulatory pathways.
The Modern Medical Affairs Leader: Then + Now
As Director- and VP-level Medical Affairs leaders oversee scientific strategy, launch readiness, evidence generation, and compliant external engagement, their role has expanded quietly but fundamentally.
Executive Brief: Making Access & Evidence Generation an Equal Partner to Commercial Planning
Market Access has long been treated as a late-stage activity, secondary to HCP marketing and addressed only after approval and launch planning.